Presentations
Public Talks Neuregulin-1 application reduces Phencyclidine-induced neurotransmitter level alterations in freely moving adult mice. Biennial Australasian Schizophrenia Conference 2013, Melbourne,...
Poster: Neuregulin-1 treatment affects GABA and glutamate release after PCP co-treatment in freely moving mice.
Poster at the annual meeting of the Society for Neuroscience (SfN) 2013, San Diego (USA) Martin Engel, Andrew Jenner, Xu-Feng...
Poster: Neuregulin-1 application reduces PCP-induced hyperlocomotion and GABA release – potential implications for schizophrenia treatment
Poster at the annual meeting of the European Brain and Behaviour Society (EBBS) 2013, Munich (Germany) Martin Engel, Xu-Feng Huang,...
QUANTITATION OF NEUROTRANSMITTERS AND METABOLITES IN MICRODIALYSATE FLUID AND BRAIN USING ADVANCED GAS CHROMATOGRAPHY-MASS SPECTROMETRY (GC-MS)
Annual meeting of the Australian Neuroscience Society 2013, Melbourne (Australia) Martin Engel, Elisabeth Frank, Andrew Jenner
Peripheral Neuregulin-1 administration suppresses PCP-induced hyperlocomotion in adult mice
Annual meeting Biological Psychiatry Australia 2012, Melbourne (Australia) Martin Engel, Xu-Feng Huang, Elisabeth Frank
PCP-induced hyperlocomotion reduced by intracerebral Neuregulin-1 application in adult mice
Biannual meeting of the Federation of European Neuroscience Societies (FENS) 2012, Barcelona (Spain) Martin Engel, Xu-Feng Huang, Elisabeth Frank
NRG1 and Schizophrenia Treatment
ANS 2012 Oral Presentation Presented at: Annual Meeting of the Australian Neuroscience Society 2012, Gold Coast , Australia. Please read...